ask="N/A"
ask_size="N/A"
average_daily_volume="57441"
bid="14.50"
bid_size="1000"
book_value="6.38"
change="-1.20"
change_from_200_day_moving_average="-1.09"
change_from_50_day_moving_average="-1.04"
change_from_52_week_high="-5.34"
change_From_52_week_low="2.34"
change_in_percent="-7.23%"
close="15.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.72"
ebitda="-48.18M"
eps_estimate_current_year="-4.11"
eps_estimate_next_quarter="-0.68"
eps_estimate_next_year="-3.46"
ex_dividend_date="N/A"
float_shares="6846000"
high="16.75"
high_52_weeks="20.74"
last_trade_date="2/22/2017"
last_trade_price="15.40"
last_trade_size="1519"
last_trade_time="4:00pm"
low="15.32"
low_52_weeks="13.06"
market_capitalization="334.57M"
moving_average_200_day="16.49"
moving_average_50_day="16.44"
name="Audentes Therapeutics
Inc."
notes="N/A"
one_year_target_price="22.33"
open="16.47"
pe_ratio="N/A"
peg_ratio="-1.56"
percent_change_from_200_day_moving_average="-6.60%"
percent_change_from_50_day_moving_average="-6.30%"
percent_change_from_52_week_high="-25.75%"
percent_change_from_52_week_low="+17.92%"
previous_close="16.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.60"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21725000"
short_ratio="14.63"
stock_exchange="NGM"
symbol="BOLD"
volume="35918"
weeks_range_52="13.06 - 20.74"
